SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
12 |
TA/BW |
1.76 |
mg/g |
0.02 |
0.07 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99023 |
2198 |
SS.BN-(D13Hmgc64-D13Hmgc23)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
12 |
TA/BW |
1.89 |
mg/g |
0.04 |
0.14 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99024 |
2198 |
SS.BN-(D13Hmgc64-4582)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
13 |
TA/BW |
1.9 |
mg/g |
0.03 |
0.11 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99028 |
2198 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
10 |
TA/BW |
1.84 |
mg/g |
0.05 |
0.16 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99044 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
10 |
TA/BW |
1.8 |
mg/g |
0.06 |
0.19 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99047 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
4 |
TA/BW |
1.74 |
mg/g |
0.08 |
0.16 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99052 |
2198 |
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
9 |
TA/BW |
1.82 |
mg/g |
0.01 |
0.03 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99019 |
2198 |
BN-Chr 13SS/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
12 |
TA/BW |
1.88 |
mg/g |
0.05 |
0.17 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99040 |
2198 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
10 |
TA/BW |
1.74 |
mg/g |
0.02 |
0.06 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99043 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
3 |
TA/BW |
1.77 |
mg/g |
0.05 |
0.09 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99055 |
2198 |
SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
9 |
TA/BW |
1.88 |
mg/g |
0.04 |
0.12 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99020 |
2198 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
14 |
TA/BW |
1.91 |
mg/g |
0.03 |
0.11 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99032 |
2198 |
SS-Chr 13BN/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
15 |
TA/BW |
1.81 |
mg/g |
0.02 |
0.08 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99035 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
10 |
TA/BW |
1.93 |
mg/g |
0.07 |
0.22 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99048 |
2198 |
SS.BN-(D13Hmgc64-4582)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
13 |
TA/BW |
1.73 |
mg/g |
0.03 |
0.11 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99027 |
2198 |
SS-Chr 13BN/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
15 |
TA/BW |
1.85 |
mg/g |
0.04 |
0.15 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99036 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) then angiotensin II (3 ng/kg/min) (for 7 days) then controlled losartan content drinking water (50 mg/kg/d) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
3 |
TA/BW |
1.88 |
mg/g |
0.04 |
0.07 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99056 |
2198 |
SS.BN-(D13Rat25-RN34_13048990782)/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
14 |
TA/BW |
1.83 |
mg/g |
0.03 |
0.11 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99031 |
2198 |
BN-Chr 13SS/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
12 |
TA/BW |
1.9 |
mg/g |
0.03 |
0.1 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99039 |
2198 |
SS/JrHsdMcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) then angiotensin II (3 ng/kg/min) (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56 days-70 days |
4 |
TA/BW |
1.68 |
mg/g |
0.04 |
0.08 |
ex vivo method |
0.0 |
0 |
TA or EDL muscle weight body weight ratio |
99051 |
2198 |